206 related articles for article (PubMed ID: 11673519)
1. Targeting of tumor cells for human gammadelta T cells by nonpeptide antigens.
Kato Y; Tanaka Y; Miyagawa F; Yamashita S; Minato N
J Immunol; 2001 Nov; 167(9):5092-8. PubMed ID: 11673519
[TBL] [Abstract][Full Text] [Related]
2. Essential requirement of antigen presentation by monocyte lineage cells for the activation of primary human gamma delta T cells by aminobisphosphonate antigen.
Miyagawa F; Tanaka Y; Yamashita S; Minato N
J Immunol; 2001 May; 166(9):5508-14. PubMed ID: 11313389
[TBL] [Abstract][Full Text] [Related]
3. Essential contribution of germline-encoded lysine residues in Jgamma1.2 segment to the recognition of nonpeptide antigens by human gammadelta T cells.
Miyagawa F; Tanaka Y; Yamashita S; Mikami B; Danno K; Uehara M; Minato N
J Immunol; 2001 Dec; 167(12):6773-9. PubMed ID: 11739492
[TBL] [Abstract][Full Text] [Related]
4. Requirement of species-specific interactions for the activation of human gamma delta T cells by pamidronate.
Kato Y; Tanaka Y; Tanaka H; Yamashita S; Minato N
J Immunol; 2003 Apr; 170(7):3608-13. PubMed ID: 12646624
[TBL] [Abstract][Full Text] [Related]
5. Involvement of CD166 in the activation of human gamma delta T cells by tumor cells sensitized with nonpeptide antigens.
Kato Y; Tanaka Y; Hayashi M; Okawa K; Minato N
J Immunol; 2006 Jul; 177(2):877-84. PubMed ID: 16818742
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of pyrophosphate-containing compounds that stimulate Vgamma2Vdelta2 T cells: application to cancer immunotherapy.
Tanaka Y; Kobayashi H; Terasaki T; Toma H; Aruga A; Uchiyama T; Mizutani K; Mikami B; Morita CT; Minato N
Med Chem; 2007 Jan; 3(1):85-99. PubMed ID: 17266628
[TBL] [Abstract][Full Text] [Related]
7. Type I IFN-mediated enhancement of anti-leukemic cytotoxicity of gammadelta T cells expanded from peripheral blood cells by stimulation with zoledronate.
Watanabe N; Narita M; Yokoyama A; Sekiguchi A; Saito A; Tochiki N; Furukawa T; Toba K; Aizawa Y; Takahashi M
Cytotherapy; 2006; 8(2):118-29. PubMed ID: 16698685
[TBL] [Abstract][Full Text] [Related]
8. Reciprocal activating interaction between dendritic cells and pamidronate-stimulated gammadelta T cells: role of CD86 and inflammatory cytokines.
Conti L; Casetti R; Cardone M; Varano B; Martino A; Belardelli F; Poccia F; Gessani S
J Immunol; 2005 Jan; 174(1):252-60. PubMed ID: 15611247
[TBL] [Abstract][Full Text] [Related]
9. Conservation of nonpeptide antigen recognition by rhesus monkey V gamma 2V delta 2 T cells.
Wang H; Lee HK; Bukowski JF; Li H; Mariuzza RA; Chen ZW; Nam KH; Morita CT
J Immunol; 2003 Apr; 170(7):3696-706. PubMed ID: 12646635
[TBL] [Abstract][Full Text] [Related]
10. Recognition mechanism of non-peptide antigens by human gammadelta T cells.
Yamashita S; Tanaka Y; Harazaki M; Mikami B; Minato N
Int Immunol; 2003 Nov; 15(11):1301-7. PubMed ID: 14565928
[TBL] [Abstract][Full Text] [Related]
11. Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens.
Iwasaki M; Tanaka Y; Kobayashi H; Murata-Hirai K; Miyabe H; Sugie T; Toi M; Minato N
Eur J Immunol; 2011 Feb; 41(2):345-55. PubMed ID: 21268005
[TBL] [Abstract][Full Text] [Related]
12. [Effect of zoledronate on the cytotoxicity of γδ T cells from PBMCs of osteosarcoma patients against osteosarcoma].
Li Z; Tang J; Sun L; Ye Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jan; 29(1):6-9. PubMed ID: 23294710
[TBL] [Abstract][Full Text] [Related]
13. MICA expressed by multiple myeloma and monoclonal gammopathy of undetermined significance plasma cells Costimulates pamidronate-activated gammadelta lymphocytes.
Girlanda S; Fortis C; Belloni D; Ferrero E; Ticozzi P; Sciorati C; Tresoldi M; Vicari A; Spies T; Groh V; Caligaris-Cappio F; Ferrarini M
Cancer Res; 2005 Aug; 65(16):7502-8. PubMed ID: 16103105
[TBL] [Abstract][Full Text] [Related]
14. Lysis of aminobisphosphonate-sensitized MCF-7 breast tumor cells by Vγ9Vδ2 T cells.
Dhar S; Chiplunkar SV
Cancer Immun; 2010 Nov; 10():10. PubMed ID: 21069948
[TBL] [Abstract][Full Text] [Related]
15. TCRVγ9 γδ T Cell Response to IL-33: A CD4 T Cell-Dependent Mechanism.
Duault C; Franchini DM; Familliades J; Cayrol C; Roga S; Girard JP; Fournié JJ; Poupot M
J Immunol; 2016 Jan; 196(1):493-502. PubMed ID: 26608919
[TBL] [Abstract][Full Text] [Related]
16. Zoledronate-activated Vγ9γδ T cell-based immunotherapy is feasible and restores the impairment of γδ T cells in patients with solid tumors.
Noguchi A; Kaneko T; Kamigaki T; Fujimoto K; Ozawa M; Saito M; Ariyoshi N; Goto S
Cytotherapy; 2011 Jan; 13(1):92-7. PubMed ID: 20831354
[TBL] [Abstract][Full Text] [Related]
17. Human gammadelta T cells as mediators of chimaeric-receptor redirected anti-tumour immunity.
Rischer M; Pscherer S; Duwe S; Vormoor J; Jürgens H; Rossig C
Br J Haematol; 2004 Aug; 126(4):583-92. PubMed ID: 15287953
[TBL] [Abstract][Full Text] [Related]
18. Contribution of Complementarity-Determining Region 3 of the T-Cell Receptor Vδ2 Chain to the Recognition of Aminobisphosphonates by Human γδ T-Cells.
Nishimura H; Hirokawa M; Fujishima N; Fujishima M; Miura I; Sawada K
Int J Hematol; 2004 May; 79(4):369-76. PubMed ID: 15218968
[TBL] [Abstract][Full Text] [Related]
19. Zoledronic acid enhances Vδ2 T-lymphocyte antitumor response to human glioma cell lines.
Cimini E; Piacentini P; Sacchi A; Gioia C; Leone S; Lauro GM; Martini F; Agrati C
Int J Immunopathol Pharmacol; 2011; 24(1):139-48. PubMed ID: 21496396
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of Vdelta1 gammadelta T cell activation by microbial components.
Das H; Sugita M; Brenner MB
J Immunol; 2004 Jun; 172(11):6578-86. PubMed ID: 15153472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
